Le Lézard
Classified in: Health
Subject: OBI

Baycrest mourns the loss of two of its visionary leaders, Barry and Honey Sherman


TORONTO, Dec. 16, 2017 /CNW/ - We at Baycrest are completely shocked and profoundly saddened by the deaths of Barry and Honey Sherman. They were visionary leaders, and their commitment and philanthropy improved the lives of countless Canadians. Barry and Honey generously helped to create the Apotex Centre, Jewish Home for the Aged at Baycrest, envisioning a facility unmatched in its service and excellence. They also recognized that research, education, and innovation are the keys to improving the journey of aging for everyone.

Barry served as a member of the Baycrest Centre Board, and as an honourary member of the Baycrest Foundation Board. Honey's longstanding dedication to Baycrest included actively participating with the Women's Auxiliary, leading many fundraising events, and serving as a member of the Baycrest Campaign Cabinet, and both the Baycrest Centre and Foundation Boards of Directors.

The Shermans' exceptional kindness and generosity helped add life to years for the many people touched by the impact of their contributions.

Baycrest extends its sincerest condolences to the entire family of Barry and Honey Sherman.

Josh Cooper

President & CEO

Baycrest Foundation

William E. Reichman, MD

President and Chief Executive Officer

Baycrest 



Garry Foster

Chair of the Board of Directors

Baycrest Foundation

David Kassie

Chair of the Board of Directors

Baycrest

 

SOURCE Baycrest Centre for Geriatric Care


These press releases may also interest you

at 19:32
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that the first patients with diabetic retinopathy...

at 19:21
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today announced that the Center for Drug...

at 18:30
Cannabix Technologies Inc. (the "Company or Cannabix") reports that it has entered into an arm's length marketing agreements with the following parties: Effective May 13, 2024, the Company has engaged Financial Buzz Media Networks LLC ("FBMN") for...

at 18:25
It is with great pleasure that we announce the Federal Commission for Protection against Health Risks (COFEPRIS) in Mexico has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks...

at 18:03
Kelyniam Global , a maker of custom cranial implants, today announced results for its quarter ended March 31, 2024.  Financial highlights for the three months ended March 31, 2024 and the same period in 2023 include:  Total revenue of $957,447...

at 17:56
American Skin Association (ASA) is thrilled to announce that the SPOTS (Sun Protection Outreach Teaching by Students) program will receive the inaugural 2024 Research Achievement Award in Community Education/Outreach at the 2024 Society for...



News published on and distributed by: